Not exact matches
One study commissioned by the makers of Paxil — GlaxoSmithKline — found that children aged 7 to 18 who
took the antidepressant were up to three
times more likely to have suicidal thoughts or display suicidal behavior
than children who received a
placebo.
A new analysis of nine studies conducted by Paxil's manufacturer, GlaxoSmithKline, showed that teenagers and children
taking Paxil were more
than three
times as likely as those
taking placebos to think about and attempt suicide.
The IPERGAY researchers found that men who have sex with men and transgender women at high risk for HIV infection who
took PrEP around the
time of sexual activity were 86 percent less likely to acquire HIV
than similar individuals who
took a
placebo.
When participants received the treatment, which was
taken by mouth, their cramps were three
times less intense
than when they received the
placebo.
After 18 months, the men
taking saw palmetto were doing no better
than those on
placebo, even though the dosage of saw palmetto was increased twice during the study, to 960 milligrams — three
times the typical daily dose.
In those studies, the percentage of people on an atypical antipsychotic who gained a clinically significant amount of weight was between 2 and 10
times greater
than the comparable rate among people
taking placebo.